BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Veppanu (Vepdegestrant) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Veppanu (Vepdegestrant)\, from ClinicalTr
 ials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07231991-9103@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261205
SUMMARY:Veppanu (Vepdegestrant): Phase 1 readout est. (NCT07231991)
DESCRIPTION:Veppanu (Vepdegestrant)\, phase 1.\nStudy: A Study to Learn How
  the Body Processes the Study Medicine Called Vepdegestrant in People With
  Loss of Liver Function\nEstimated primary completion: 4 December 2026. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/vepdegestrant#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07231991
URL:https://assetmemo.bio/drug/vepdegestrant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05909397-9103@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Veppanu (Vepdegestrant): Phase 3 readout est. (NCT05909397)
DESCRIPTION:Veppanu (Vepdegestrant)\, phase 3\, HR+/HER2- Metastatic Breast
  Cancer.\nStudy: Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letr
 ozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer\nEstimated pri
 mary completion: 30 December 2026. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/vepdegestrant#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT05909397
URL:https://assetmemo.bio/drug/vepdegestrant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05548127-9103@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20270324
DTEND;VALUE=DATE:20270325
SUMMARY:Veppanu (Vepdegestrant): Phase 1/2 readout est. (NCT05548127)
DESCRIPTION:Veppanu (Vepdegestrant)\, phase 1/2\, HR+/HER2- Metastatic Brea
 st Cancer.\nStudy: TACTIVE-U: A Study to Learn About the Study Medicine (V
 epdegestrant) When Given With Other Medicines in People With Advanced or M
 etastatic Breast Cancer (Sub-Study A)\nEstimated primary completion: 24 Ma
 rch 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/vepdegestra
 nt#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 5548127
URL:https://assetmemo.bio/drug/vepdegestrant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04606446-9103@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20290827
DTEND;VALUE=DATE:20290828
SUMMARY:Veppanu (Vepdegestrant): Phase 2 readout est. (NCT04606446)
DESCRIPTION:Veppanu (Vepdegestrant)\, phase 2\, HR+/HER2- Metastatic Breast
  Cancer.\nStudy: Study of PF-07248144 in Advanced or Metastatic Solid Tumo
 rs\nEstimated primary completion: 27 August 2029. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/vepdegestrant#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT04606446
URL:https://assetmemo.bio/drug/vepdegestrant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT01042379-9103@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20301231
DTEND;VALUE=DATE:20310101
SUMMARY:Veppanu (Vepdegestrant): Phase 2 readout est. (NCT01042379)
DESCRIPTION:Veppanu (Vepdegestrant)\, phase 2\, Breast Cancer.\nStudy: I-SP
 Y TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breas
 t Cancer\nEstimated primary completion: December 2030. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/vepdegestrant#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT01042379
URL:https://assetmemo.bio/drug/vepdegestrant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
